We are live on ! Find out more
A

AustralianSuper Portfolio holdings

AUM $19.2B
1-Year Est. Return 31.95%
This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+31.95%
3 Year Est. Return
+101.58%
5 Year Est. Return
+115.19%
10 Year Est. Return
AUM
$15.8B
AUM Growth
-$654M
Cap. Flow
-$1.91B
Cap. Flow %
-12.09%
Top 10 Hldgs %
37.93%
Holding
308
New
101
Increased
72
Reduced
82
Closed
45

Top Sells

Rank Stock Value
1
ICL icon
ICL Group
ICL
+$1.33B
2
TSEM icon
Tower Semiconductor
TSEM
+$588M
3
MSFT icon
Microsoft
MSFT
+$481M
4
AAPL icon
Apple
AAPL
+$415M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$213M

Sector Composition

Rank Sector Weight
1 Technology 19.49%
2 Consumer Discretionary 18.75%
3 Financials 16.97%
4 Healthcare 15.6%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOC icon
26
Northrop Grumman
NOC
$74.1B
$179M 1.14%
393,488
-9,576
-2% -$4.34M
CRM icon
27
Salesforce
CRM
$140B
$172M 1.09%
812,942
+62,556
+8% +$12.8M
AMT icon
28
American Tower
AMT
$79.2B
$168M 1.06%
865,026
-26,582
-3% -$5.2M
SCHW
29
Charles Schwab
SCHW
$177B
$144M 0.92%
+2,546,122
New +$133M
KO icon
30
Coca-Cola
KO
$351B
$139M 0.88%
2,305,393
+269,805
+13% +$16.8M
BKNG icon
31
Booking.com
BKNG
$141B
$135M 0.86%
1,249,950
-67,700
-5% -$7.15M
ACN icon
32
Accenture
ACN
$87.9B
$134M 0.85%
434,158
+69,483
+19% +$20.2M
ICLR icon
33
Icon
ICLR
$13.1B
$131M 0.83%
522,828
-25,101
-5% -$5.33M
TMO icon
34
Thermo Fisher Scientific
TMO
$198B
$127M 0.8%
242,709
+47,505
+24% +$25.6M
WST icon
35
West Pharmaceutical
WST
$25.3B
$122M 0.78%
319,771
-10,494
-3% -$3.75M
HD icon
36
Home Depot
HD
$338B
$119M 0.75%
+381,552
New +$113M
NFLX icon
37
Netflix
NFLX
$290B
$112M 0.71%
+2,531,830
New +$93.3M
NKE icon
38
Nike
NKE
$64.9B
$107M 0.68%
972,549
+166,255
+21% +$19.4M
MSCI icon
39
MSCI
MSCI
$45.8B
$100M 0.64%
+213,847
New +$104M
STLA icon
40
Stellantis
STLA
$16.8B
$99.7M 0.63%
5,676,050
+405,520
+8% +$6.8M
MCO icon
41
Moody's
MCO
$89.2B
$99.4M 0.63%
285,756
+50,298
+21% +$15.9M
PFE icon
42
Pfizer
PFE
$143B
$99M 0.63%
+2,699,022
New +$105M
BDX icon
43
Becton Dickinson
BDX
$43.6B
$96.9M 0.61%
367,043
+59,438
+19% +$15.1M
NVDA icon
44
NVIDIA
NVDA
$4.91T
$96M 0.61%
+2,269,550
New +$75.4M
ZTS icon
45
Zoetis
ZTS
$32.1B
$95.7M 0.61%
555,782
+71,614
+15% +$12.4M
NUE icon
46
Nucor
NUE
$53.9B
$94.1M 0.6%
573,692
-46,868
-8% -$6.84M
DG icon
47
Dollar General
DG
$27.7B
$93.7M 0.59%
551,971
-328,582
-37% -$65M
MCK icon
48
McKesson
MCK
$98.5B
$93.5M 0.59%
218,768
-60,721
-22% -$23.3M
COF icon
49
Capital One
COF
$128B
$91M 0.58%
+832,461
New +$83.3M
HPQ icon
50
HP
HPQ
$22.7B
$90.5M 0.57%
2,947,191
+221,873
+8% +$6.66M

Similar funds

AustralianSuper's Q2 2023 Portfolio in Review

As of Q2 2023, AustralianSuper held 308 positions worth $15.8B, down 4% from $16.4B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

AustralianSuper withdrew a net $1.91B in Q2 2023, closing 45 positions and reducing 82 holdings. Its most notable exit was ICL Group, an estimated $1.33B position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, AustralianSuper opened a new position in Charles Schwab worth $144M.

  • AustralianSuper's largest Q2 2023 buy was Charles Schwab: 2,546,122 shares worth $144M.
  • AustralianSuper added most to Amazon in Q2 2023, an estimated $658M increase.
  • AustralianSuper's biggest Q2 2023 reduction was Microsoft, cutting an estimated $481M.
  • AustralianSuper fully exited ICL Group in Q2 2023, selling an estimated $1.33B.
  • AustralianSuper's ten largest holdings make up 38% of its $15.8B portfolio in Q2 2023.
  • AustralianSuper opened 101 new positions and closed 45 in Q2 2023.
  • AustralianSuper's portfolio value fell 4% quarter-over-quarter to $15.8B.

Based on AustralianSuper's 13F filing for Q2 2023, filed 28 Jul 2023.